Tools · Private company

Exosome Diagnostics, Inc.

Track this companyFree. Adds Exosome Diagnostics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials81 recruiting or active

Pipeline programs4From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline4

ExoDx ProstateProstate CancerClinicalTrials.gov · fetched Nov 12, 2026
ExoDx Prostate (IntelliScore)Cancer of the ProstateClinicalTrials.gov · fetched Nov 12, 2026
ExoDx Prostate IntelliscoreCancer of ProstateClinicalTrials.gov · fetched Nov 12, 2026
ExoDx Prostate(IntelliScore)Urologic CancerClinicalTrials.gov · fetched Nov 12, 2026

ExoDx Prostate Evaluation in Active Surveillance Patient PopulationUNKNOWN · started Oct 1, 2022ClinicalTrials.gov NCT05572099 · fetched Nov 12, 2026
Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate BiopsyCOMPLETED · started Jun 1, 2020ClinicalTrials.gov NCT04720599 · fetched Nov 12, 2026
ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy SettingTERMINATED · started Mar 15, 2020ClinicalTrials.gov NCT04357717 · fetched Nov 12, 2026
Decision Impact Trial of the ExoDx Prostate (IntelliScore)NA · UNKNOWN · started Jul 19, 2017ClinicalTrials.gov NCT03235687 · fetched Nov 12, 2026
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT03031418 · fetched Nov 12, 2026
Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)SUSPENDED · started Feb 1, 2016ClinicalTrials.gov NCT03236688 · fetched Nov 12, 2026
Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC PatientsUNKNOWN · started Mar 1, 2015ClinicalTrials.gov NCT03236675 · fetched Nov 12, 2026
Molecular Studies and Clinical Correlations in Human Prostatic DiseaseACTIVE_NOT_RECRUITING · started Apr 1, 1990ClinicalTrials.gov NCT00578240 · fetched Nov 12, 2026